Regeneron Pharmaceuticals Inc - Results for Q2 to Include Acquired in-Process Research & Development Charge of About $24 Mln on a Pre-Tax Basis
再生元製藥公司 - Q2的結果將包括約2400萬美元的研發費用的攤銷(稅前)
Regeneron Pharmaceuticals Inc - Results for Q2 to Include Acquired in-Process Research & Development Charge of About $24 Mln on a Pre-Tax Basis
再生元製藥公司 - Q2的結果將包括約2400萬美元的研發費用的攤銷(稅前)
譯文內容由第三人軟體翻譯。